✦ LIBER ✦

869: Transcriptome and pathway analysis identifies IRF1 as a predictor of progression free and overall survival in ovarian carcinoma

✍ Scribed by Billaud, J.; Cohen, S.; Mosig, R.; Halpert, R.; Dottino, P.; Martignetti, J.

Book ID: 125796771
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 66 KB
Volume: 50
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(14)50772-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Progression-free survival as a predictor

Progression-free survival as a predictor of overall survival in metastatic renal cell carcinoma treated with contemporary targeted therapy

✍ Daniel Y. C. Heng; Wanling Xie; Georg A. Bjarnason; Ulka Vaishampayan; Min-Han T 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 238 KB

L1 expression as a predictor of progress

L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas

✍ Mina Fogel; Paul Gutwein; Sabine Mechtersheimer; Svenja Riedle; Alexander Stoeck 📂 Article 📅 2003 🏛 The Lancet 🌐 English ⚖ 688 KB

The prediction of progression-free and o

The prediction of progression-free and overall survival in women with an advanced stage of epithelial ovarian carcinoma

✍ CG Gerestein; MJC Eijkemans; D de Jong; MEL van der Burg; RHM Dykgraaf; GS Kooi; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB

Improved progression-free and overall su

Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm

✍ Dennis S. Chi; Eric L. Eisenhauer; Oliver Zivanovic; Yukio Sonoda; Nadeem R. Abu 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 377 KB

CA125 level as a predictor of progressio

CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapy

✍ Margrit M. Juretzka; Richard R. Barakat; Dennis S. Chi; Alexia Iasonos; Jakob Du 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 347 KB

Minimal Residual Disease Quantification

Minimal Residual Disease Quantification Is an Independent Predictor of Progression-Free and Overall Survival in Chronic Lymphocytic Leukemia: A Multivariate Analysis From the Randomized GCLLSG CLL8 Trial

✍ Bottcher, S.; Ritgen, M.; Fischer, K.; Stilgenbauer, S.; Busch, R. M.; Fingerle- 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 272 KB